---
ontology: cell-ontology
issue_number: 3458
pr_number: 3505
eval_repo_pr: 280
agent: std_claude_opus47
model: claude-opus-4.7
runtime: claude
agent_config_tag: ai4curation/cl-agent-config@v3
case_type: new_term
difficulty: medium
f1: 0.615
precision: 0.727
recall: 0.533
jaccard: 0.444
outcome: success
failure_modes: [over_editing]
reviewed_by: claude-opus-4.7
reviewed_at: 2026-05-16
---

## Summary

This attempt (claude-opus-4.7) added `fibrochondrocyte progenitor cell` with the correct canonical placeholder ID `CL_9900000` (matching gold PR #3505), correct label, FCP synonym, PMID-referenced definition, dual parentage under mesenchymal cell (`CL_0008019`) and progenitor cell (`CL_0011026`), and `part_of` `UBERON_0001995` (fibrocartilage). The core term is modeled correctly and matches gold's structure. The F1 of 0.615 under-represents correctness but legitimately reflects scope creep: this attempt added four `expresses` marker axioms (the most of any attempt) — gold added none — plus an extra free-text related synonym, lowering recall against the conservative gold reference.

## Strengths

- Correct ID range and exact canonical ID `CL_9900000`, matching gold and complying with the agent config's CL_99xxxxx mandate.
- Definition with dual PMID xrefs, FCP related synonym with `OMO_0003000` abbreviation synonym type, and label assertion are structurally faithful to gold.
- Parentage and `BFO_0000050` some `UBERON_0001995` location axioms exactly match gold.
- Used asserted `SubClassOf` axioms (not an over-strong `EquivalentClasses`), consistent with gold's conservative modeling.
- Attempted to formalize all four requested markers with plausible PRO IDs: `PR_000003264` (COL1A1) and `PR_000003328` (COL3A1) match existing CL_4072104 practice; `PR_000001127` (MCAM/CD146) and `PR_000010845` (MYLK) are reasonable PRO lookups for the issue's requested markers.

## Issues

- Over-editing / recall: added four `expresses` (RO_0002292) marker axioms. While the issue text requested these markers, the gold PR deliberately omitted all marker axioms (reviewer steered toward conservative, non-in-vitro modeling). This is the largest source of recall loss and is the primary failure mode here. The extra markers are defensible against the literal issue but diverge from the curated gold.
- Scope: added a second related synonym `"fibrochondrocyte progenitor"` (with `PMID:31871141`) that neither the issue nor gold included — minor gratuitous addition.
- Omission: did not add gold's reciprocal `SubClassOf(obo:CL_4072104 ObjectSomeValuesFrom(obo:RO_0002202 obo:CL_9900000))` develops_from axiom on the fibrochondrocyte term.
- Minor: used `terms:date` and `IAO_0000233` issue-tracker annotation absent from gold; metadiff-normalized provenance noise, not a substantive defect.
- Style: kept the in-vitro colony-forming/multi-lineage text inside the main `IAO_0000115` definition rather than splitting to `rdfs:comment` as the reviewer requested and gold did (reviewer feedback was not in agent input, so this is understandable).
